Search

Your search keyword '"Harris, Samuel J."' showing total 112 results

Search Constraints

Start Over You searched for: Author "Harris, Samuel J." Remove constraint Author: "Harris, Samuel J."
112 results on '"Harris, Samuel J."'

Search Results

1. Modelling wildfire spread and spotfire merger using conformal mapping and AAA-least squares methods

2. Universality of graph homomorphism games and the quantum coloring problem

3. Penguin huddling: a continuum model

5. Quantum no-signalling bicorrelations

6. Crossed Product Equivalence of Quantum Automorphism Groups

7. Synchronous games with $*$-isomorphic game algebras

9. Synchronicity for quantum non-local games

10. The quantum-to-classical graph homomorphism game

13. Schur multipliers and mixed unitary maps

14. Bipartite matrix-valued tensor product correlations that are not finitely representable

15. Crossed products of operator systems

16. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

17. Quantum Teleportation and Super-dense Coding in Operator Algebras

18. Connes' Embedding Problem and Winning Strategies for Quantum XOR Games

19. Unitary Correlation Sets

22. A Non-Commutative Unitary Analogue of Kirchberg's Conjecture

23. Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study

29. Crossed Product Equivalence of Quantum Automorphism Groups of Finite Dimensional C*-Algebras.

32. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

36. Adjuvant chemotherapy guided by circulating tumor DNA analysis in stage II colon cancer: The randomized DYNAMIC trial.

37. Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: An application of the TARGET-TP score.

39. Lower COVID-19 vaccination rates amongst Australians with gastrointestinal (GI) compared to other cancers.

40. sj-docx-1-ctj-10.1177_17407745221090733 – Supplemental material for Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: A scoping review

42. Quantum Teleportation and Super-Dense Coding in Operator Algebras.

47. Abstract 3081: Precision medicine for patients with advanced small cell lung cancer treated with novel therapeutic agents in a phase I clinical trials unit

49. Immuno-oncology combinations: raising the tail of the survival curve.

Catalog

Books, media, physical & digital resources